These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38678364)

  • 1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.
    Marchal A; Cirulli ET; Neveux I; Bellos E; Thwaites RS; Schiabor Barrett KM; Zhang Y; Nemes-Bokun I; Kalinova M; Catchpole A; Tangye SG; Spaan AN; Lack JB; Ghosn J; Burdet C; Gorochov G; Tubach F; Hausfater P; ; ; ; ; ; ; ; ; ; Dalgard CL; Zhang SY; Zhang Q; Chiu C; Fellay J; Grzymski JJ; Sancho-Shimizu V; Abel L; Casanova JL; Cobat A; Bolze A
    HGG Adv; 2024 Jul; 5(3):100300. PubMed ID: 38678364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between HLA and asymptomatic SARS-CoV-2 infection.
    Marchal A; Cirulli ET; Neveux I; Bellos E; Thwaites RS; Schiabor Barrett KM; Zhang Y; Nemes-Bokun I; Kalinova M; Catchpole A; Tangye SG; Spaan AN; Lack JB; Ghosn J; Burdet C; Gorochov G; Tubach F; Hausfater P; ; ; ; ; ; ; ; ; ; Dalgard CL; Zhang SY; Zhang Q; Chiu C; Fellay J; Grzymski JJ; Sancho-Shimizu V; Abel L; Casanova JL; Cobat A; Bolze A
    medRxiv; 2023 Dec; ():. PubMed ID: 38168184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
    Augusto DG; Murdolo LD; Chatzileontiadou DSM; Sabatino JJ; Yusufali T; Peyser ND; Butcher X; Kizer K; Guthrie K; Murray VW; Pae V; Sarvadhavabhatla S; Beltran F; Gill GS; Lynch KL; Yun C; Maguire CT; Peluso MJ; Hoh R; Henrich TJ; Deeks SG; Davidson M; Lu S; Goldberg SA; Kelly JD; Martin JN; Vierra-Green CA; Spellman SR; Langton DJ; Dewar-Oldis MJ; Smith C; Barnard PJ; Lee S; Marcus GM; Olgin JE; Pletcher MJ; Maiers M; Gras S; Hollenbach JA
    Nature; 2023 Aug; 620(7972):128-136. PubMed ID: 37468623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
    Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
    Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between human leukocyte antigen alleles and COVID-19 disease severity.
    Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M
    J Infect Public Health; 2024 Sep; 17(9):102498. PubMed ID: 39173558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
    Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
    Front Immunol; 2020; 11():605688. PubMed ID: 33343579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC Variants Associated With Symptomatic
    Castelli EC; de Castro MV; Naslavsky MS; Scliar MO; Silva NSB; Andrade HS; Souza AS; Pereira RN; Castro CFB; Mendes-Junior CT; Meyer D; Nunes K; Matos LRB; Silva MVR; Wang JYT; Esposito J; Coria VR; Bortolin RH; Hirata MH; Magawa JY; Cunha-Neto E; Coelho V; Santos KS; Marin MLC; Kalil J; Mitne-Neto M; Maciel RMB; Passos-Bueno MR; Zatz M
    Front Immunol; 2021; 12():742881. PubMed ID: 34650566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort).
    Hopkins G; Gomez N; Tucis D; Bartlett L; Steers G; Burns E; Brown M; Harvey-Cowlishaw T; Santos R; Lauder SN; Scurr M; Capitani L; Burnell S; Rees T; Smart K; Somerville M; Gallimore A; Perera M; Potts M; Metaxaki M; Krishna B; Jackson H; Tighe P; Onion D; Godkin A; Wills M; Fairclough L
    J Clin Immunol; 2024 Jun; 44(6):147. PubMed ID: 38856804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
    Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y
    J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity.
    Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F
    Front Immunol; 2022; 13():769900. PubMed ID: 35185875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia.
    Tanaka K; Meguro A; Hara Y; Endo L; Izawa A; Muraoka S; Kaneko A; Somekawa K; Hirata M; Otsu Y; Matsumoto H; Nagasawa R; Kubo S; Murohashi K; Aoki A; Fujii H; Watanabe K; Horita N; Kato H; Kobayashi N; Takeuchi I; Nakajima A; Inoko H; Mizuki N; Kaneko T
    HLA; 2024 Jul; 104(1):e15609. PubMed ID: 39041300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    ; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL
    JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
    Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.
    Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L
    Front Immunol; 2024; 15():1357731. PubMed ID: 38784379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity.
    Amoroso A; Magistroni P; Vespasiano F; Bella A; Bellino S; Puoti F; Alizzi S; Vaisitti T; Boros S; Grossi PA; Trapani S; Lombardini L; Pezzotti P; Deaglio S; Brusaferro S; Cardillo M;
    Transplantation; 2021 Jan; 105(1):193-200. PubMed ID: 33141807
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Naidoo L; Arumugam T; Ramsuran V
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
    Migliorini F; Torsiello E; Spiezia F; Oliva F; Tingart M; Maffulli N
    Eur J Med Res; 2021 Aug; 26(1):84. PubMed ID: 34344463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individuals carrying the HLA-B*15 allele exhibit favorable responses to COVID-19 vaccines but are more susceptible to Omicron BA.5.2 and XBB.1.16 infection.
    Meng L; Pan Y; Liu Y; He R; Sun Y; Wang C; Fei L; Zhu A; Wang Z; An Y; Wu Y; Diao B; Chen Y
    Front Immunol; 2024; 15():1440819. PubMed ID: 39257586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
    Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
    Front Immunol; 2021; 12():627568. PubMed ID: 33995351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.